1. Chabner BA, Myers CE: Clinical pharmacology of cancer chemotherapy. In: DeVita VT Jr, Hellman S, Rosenberg SA eds, Cancer; Principles and Practice of Oncology, 2nd ed, J. B. Lippincott Company, Philadelphia, pp287–328, 1985.
2. Casazza AM, Isetta AM, Giuliani F,et al: Immunodepressive activity of daunomycin and adriamycin. In: Staquet M, Tagnon H, Kenis Y,et al eds, Daunomycin and Adriamycin, European Press, Belgium, pp123–131, 1975.
3. Dillman RO: Monoclonal antibodies in the treatment of cancer.Crit Rev Oncol Hematol 1:357–386, 1984.
4. Oldman RK: Immunoconjugates; Drug Toxins, Raven Press, New York, pp319–336, 1987.
5. Dillman RO, Johnson DE, Shawler D,et al: Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.Cancer Res 48:6097–6102, 1988.